DK2696885T3 - Fremgangsmåder til håndtering og behandling af kroniske smerter ved anvendelse af hcg - Google Patents

Fremgangsmåder til håndtering og behandling af kroniske smerter ved anvendelse af hcg Download PDF

Info

Publication number
DK2696885T3
DK2696885T3 DK12771099.4T DK12771099T DK2696885T3 DK 2696885 T3 DK2696885 T3 DK 2696885T3 DK 12771099 T DK12771099 T DK 12771099T DK 2696885 T3 DK2696885 T3 DK 2696885T3
Authority
DK
Denmark
Prior art keywords
hcg
procedures
handling
chronic pain
treating chronic
Prior art date
Application number
DK12771099.4T
Other languages
English (en)
Inventor
Edson Conrad Hicks Jr
Constance T Dutton
Original Assignee
Neuralight Hd Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/211,101 external-priority patent/US8680086B2/en
Application filed by Neuralight Hd Llc filed Critical Neuralight Hd Llc
Application granted granted Critical
Publication of DK2696885T3 publication Critical patent/DK2696885T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A61M5/284—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle comprising means for injection of two or more media, e.g. by mixing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533—Dosing mechanisms, i.e. setting a dose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533—Dosing mechanisms, i.e. setting a dose
    • A61M5/31545—Setting modes for dosing
    • A61M5/31548—Mechanically operated dose setting member
    • A61M5/3155—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A61M2205/6063—Optical identification systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicinal Preparation (AREA)
DK12771099.4T 2011-04-15 2012-04-16 Fremgangsmåder til håndtering og behandling af kroniske smerter ved anvendelse af hcg DK2696885T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161475908P 2011-04-15 2011-04-15
US13/211,101 US8680086B2 (en) 2011-04-15 2011-08-16 Methods for chronic pain management and treatment using HCG
US13/311,250 US20120265129A1 (en) 2011-04-15 2011-12-05 Methods for Chronic Pain Management and Treatment using HCG
PCT/US2012/033828 WO2012142609A1 (en) 2011-04-15 2012-04-16 Methods for chronic pain management and treatment using hcg

Publications (1)

Publication Number Publication Date
DK2696885T3 true DK2696885T3 (da) 2020-02-03

Family

ID=47006948

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12771099.4T DK2696885T3 (da) 2011-04-15 2012-04-16 Fremgangsmåder til håndtering og behandling af kroniske smerter ved anvendelse af hcg

Country Status (12)

Country Link
US (3) US20120265129A1 (da)
EP (1) EP2696885B1 (da)
JP (3) JP2014510797A (da)
KR (1) KR102029187B1 (da)
CN (2) CN107469072A (da)
AU (1) AU2012242443C1 (da)
BR (1) BR112013026284B1 (da)
CA (1) CA2864875C (da)
DK (1) DK2696885T3 (da)
MX (1) MX359672B (da)
RU (2) RU2755938C2 (da)
WO (1) WO2012142609A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120265129A1 (en) 2011-04-15 2012-10-18 Neuralight Hd, Llc Methods for Chronic Pain Management and Treatment using HCG
US8680086B2 (en) 2011-04-15 2014-03-25 Neuralight Hd, Llc Methods for chronic pain management and treatment using HCG
WO2014063071A1 (en) * 2012-10-18 2014-04-24 Neuralight Hd, Llc Treatment of depression and ptsd
WO2016077565A2 (en) * 2014-11-12 2016-05-19 Neuralight Hd, Llc Methods for chronic pain management and treatment using hcg
US10143625B2 (en) 2015-03-17 2018-12-04 Recon Therapeutics, Inc. Pharmaceutical reconstitution
US20220175701A1 (en) * 2020-12-08 2022-06-09 Therapeutic Solutions International, Inc. Treatment of major depressive disorder and suicidal ideations through stimulation of hippocampal neurogenesis utilizing plant-based approaches

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689222A (en) 1985-01-18 1987-08-25 Mcmichael John Methods and materials for alleviation of pain symptoms of malignant neoplasia
IL86799A (en) * 1987-07-02 1993-03-15 Kabi Pharmacia Ab Method and device for injection
US5384132A (en) 1990-03-20 1995-01-24 Akzo N.V. Stabilized gonadotropin containing preparations
US5677275A (en) 1994-08-05 1997-10-14 The United States Of America As Represented By The Department Of Health And Human Services Treatment of cancer with human chorionic gonadotropin
AU707796B2 (en) 1995-03-21 1999-07-22 Merck Serono Sa HCG liquid formulations
IL122732A0 (en) 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
US6488649B1 (en) 1998-11-24 2002-12-03 Edward M. Lichten Implant device
US6417184B1 (en) * 2000-09-19 2002-07-09 David M. Ockert Triple drug therapy for the treatment and prevention of acute or chronic pain
US20020123670A1 (en) * 2000-12-29 2002-09-05 Goetzke Gary A. Chronic pain patient diagnostic system
MEP39208A (en) * 2001-09-12 2011-02-10 Merck Serono Sa USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US7101847B2 (en) * 2002-10-11 2006-09-05 Milkhaus Laboratory, Inc. Method of treating chronic pelvic pain syndrome by administration of chorionic gonadotropin
AU2003212569A1 (en) * 2003-02-07 2004-08-30 Ambros Valentin Huber Use of human chorionic gonadotropin in the treatment in the treatment of symptoms caused by endometriosis
US7517529B2 (en) * 2003-04-08 2009-04-14 Biotempt B.V. Treatment of type I diabetes
JP2009530234A (ja) * 2006-03-17 2009-08-27 ステム セル セラピューティクス コーポレイション 神経変性疾患の治療のためのｌｈまたはｈｃｇ、およびｅｐｏについての投与レジメン
CN1865944A (zh) * 2006-06-15 2006-11-22 福州大学 无创定量hcg检测方法
US20120265129A1 (en) 2011-04-15 2012-10-18 Neuralight Hd, Llc Methods for Chronic Pain Management and Treatment using HCG
US8680086B2 (en) 2011-04-15 2014-03-25 Neuralight Hd, Llc Methods for chronic pain management and treatment using HCG

Also Published As

Publication number Publication date
RU2017112735A3 (da) 2020-08-03
CN107469072A (zh) 2017-12-15
JP2019189660A (ja) 2019-10-31
US20150057224A1 (en) 2015-02-26
EP2696885B1 (en) 2019-11-20
RU2017112735A (ru) 2019-01-25
RU2013150024A (ru) 2015-05-20
KR20140043731A (ko) 2014-04-10
EP2696885A4 (en) 2014-11-05
JP2017206500A (ja) 2017-11-24
US20130196914A1 (en) 2013-08-01
RU2755938C2 (ru) 2021-09-23
WO2012142609A1 (en) 2012-10-18
EP2696885A1 (en) 2014-02-19
AU2012242443B2 (en) 2015-12-10
JP6571713B2 (ja) 2019-09-04
MX2013012078A (es) 2015-08-06
MX359672B (es) 2018-10-05
BR112013026284B1 (pt) 2022-09-20
US20120265129A1 (en) 2012-10-18
AU2012242443A1 (en) 2013-05-02
CA2864875C (en) 2020-08-18
US8680088B2 (en) 2014-03-25
AU2012242443C1 (en) 2016-06-16
CA2864875A1 (en) 2012-10-18
CN103596647A (zh) 2014-02-19
JP2014510797A (ja) 2014-05-01
BR112013026284A2 (pt) 2020-08-11
KR102029187B1 (ko) 2019-10-07

Similar Documents

Publication Publication Date Title
HK1201145A1 (en) Methods and devices for treating hypertension
DK2900061T3 (da) Fremgangsmåde til forstærkning af specifikke immunterapier ved cancerbehandling
DK3045187T3 (da) Injektor og fremgangsmåde til samling
DK2702767T3 (da) Apparater og fremgangsmåder til hdr-billedkodning og -afkodning
EP2696792A4 (en) SYSTEM AND METHOD FOR THE TREATMENT OF THE MAGIC / FOOD TUBE REFLUX DISEASE
DK2925782T3 (da) Anti-cd47-antistoffer og fremgangsmåder til anvendelse deraf
DK2769772T3 (da) Anordning og fremgangsmåde til rørcoating
DK2950535T3 (da) Fremgangsmåde og indretning til at afkode intra-forudsigelsestilstand
DK2785744T3 (da) Proteininhibitorer til komplement- og vegf-pathways og fremgangsmåder til anvendelse deraf
DK2692026T3 (da) Forspændingselement til fastholdelse af kontinuitet og tilknyttet fremgangsmåde
DK2838900T3 (da) Forbindelser og fremgangsmåder til antiviral behandling
DK3141542T3 (da) Substituerede benzaldehydforbindelser og fremgangsmåder til anvendelse deraf ved øgning af vævsiltning
DK2890780T3 (da) Fremgangsmåder og sammensætninger til behandling af en genetisk tilstand
DK3468197T3 (da) Fremgangsmåde til interforudsigelse og indretning dertil
DK2428450T3 (da) Doseringsmetode og doseringsindretning
DK3838923T3 (da) Antistoffer og vacciner til anvendelse ved behandling af ror1-cancere og hæmning af metastase
DK2683406T3 (da) Anti-cd40-antistoffer og anvendelser deraf
DK2699397T3 (da) Apparater, system og fremgangsmåder til at danne pressede artikler og pressede artikler dannet derved
DK2863391T3 (da) Fremgangsmåde og indretning til fjernelse af efterklang af enkanal-tale
DK3223284T3 (da) Fremgangsmåde til dannelse og opretholdelse af højydelses-frc
DK3269386T3 (da) Aluminiumforbindelser til anvendelse inden for behandling og i vacciner
DK2941258T3 (da) Sammensætninger og fremgangsmåder til behandling af cancer ved anvendelse af bakterier
DK3550836T3 (da) Fremgangsmåde og anordning til afkodning
DK3197164T3 (da) Afkodningsanordning og afkodningsfremgangsmåde
DK3703403T3 (da) Fremgangsmåde og indretning til caching